Finding new uses for older drugs is the objective of a European repurposing project that will begin in early 2020.
A pilot EU project that will encourage non-industry bodies to research new uses for authorized medicines is scheduled to be launched in the first quarter of 2020, according to the European Medicines Agency.
The drug repurposing project, which has been under development since 2016, is led by a working group of the European Commission’s STAMP (Safe and Timely Access to Medicines for Patients)...
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
